FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296162018> ?p ?o ?g. }

• W4296162018 endingPage "198909" @default.
• W4296162018 startingPage "198909" @default.
• W4296162018 abstract "Combination therapy of bacteriophages and antibiotics requires careful selection of specific antibiotics as it is crucial towards determining the success of phage therapy to treat multiple drug-resistant bacterial infections. So, we examined how different antibiotics can affect phage lytic activity when used in combination against targeted bacteria. Various antibiotics targeting bacterial protein synthesis pathways were tested for their bactericidal action in combination with bacteriophages of Acinetobacter baumannii (φAB145, φAB182), Staphylococcus aureus (φSA115, φSA116) and Salmonella Typhimurium (φST143, φST188). The phages displayed highly significant antagonism with most of the protein/ribosomal machinery targeting antibiotics: φSA115 (13/13); φSA116 (13/13); φST143 (11/13); φAB145 (11/13); φST188 (9/13); φAB182 (7/13). To validate this antagonistic effect, synergy assessment of these phages with gentamicin (GEN) and tetracycline (TE) was performed using time kill curve assays and counting the remaining viable bacterial cells at the end of the experiment. An increase in bacterial turbidity in phage-antibiotic combination groups was observed as compared to the treatment with phages individually. Also, GEN exhibited 4.22, 5.90, 2.02, 3.15, 2.68, and 2.60 log proliferation in viable cell count, respectively, for φSA115, φSA116, φST145, φAB182, φST143 and φAB188 in combination group in comparison to their individual actions. TE supplementation also led to 2.40, 4.90, 1.61, 2.73, 3.93, and 1.81 log increments in viable bacterial count when combined with φSA115, φSA116, φST145, φAB182, φST143 and φAB188, respectively. This study concludes that antibiotics targeting the bacterial protein biosynthetic machinery may lead to a reduction in the lytic activity of bacteriophages, thus lowering their therapeutic potential. Hence, such compounds must be carefully screened before their employment in combination treatment regimens." @default.
• W4296162018 created "2022-09-18" @default.
• W4296162018 creator A5005120466 @default.
• W4296162018 creator A5021494014 @default.
• W4296162018 creator A5022360873 @default.
• W4296162018 creator A5038108294 @default.
• W4296162018 creator A5052404508 @default.
• W4296162018 creator A5054003874 @default.
• W4296162018 date "2022-11-01" @default.
• W4296162018 modified "2023-09-26" @default.
• W4296162018 title "Antibiotics targeting bacterial protein synthesis reduce the lytic activity of bacteriophages" @default.
• W4296162018 cites W1998566510 @default.
• W4296162018 cites W2007806539 @default.
• W4296162018 cites W2086919865 @default.
• W4296162018 cites W2090817404 @default.
• W4296162018 cites W2099798492 @default.
• W4296162018 cites W2115140590 @default.
• W4296162018 cites W2121992995 @default.
• W4296162018 cites W2128453909 @default.
• W4296162018 cites W2517520375 @default.
• W4296162018 cites W2747615902 @default.
• W4296162018 cites W2790955358 @default.
• W4296162018 cites W2804154781 @default.
• W4296162018 cites W2890653912 @default.
• W4296162018 cites W2896832238 @default.
• W4296162018 cites W2897254003 @default.
• W4296162018 cites W2932477481 @default.
• W4296162018 cites W3034722728 @default.
• W4296162018 cites W3038091686 @default.
• W4296162018 cites W3047234466 @default.
• W4296162018 cites W3093303800 @default.
• W4296162018 cites W3154654640 @default.
• W4296162018 cites W3161336598 @default.
• W4296162018 cites W4229046765 @default.
• W4296162018 doi "https://doi.org/10.1016/j.virusres.2022.198909" @default.
• W4296162018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36057417" @default.
• W4296162018 hasPublicationYear "2022" @default.
• W4296162018 type Work @default.
• W4296162018 citedByCount "1" @default.
• W4296162018 countsByYear W42961620182023 @default.
• W4296162018 crossrefType "journal-article" @default.
• W4296162018 hasAuthorship W4296162018A5005120466 @default.
• W4296162018 hasAuthorship W4296162018A5021494014 @default.
• W4296162018 hasAuthorship W4296162018A5022360873 @default.
• W4296162018 hasAuthorship W4296162018A5038108294 @default.
• W4296162018 hasAuthorship W4296162018A5052404508 @default.
• W4296162018 hasAuthorship W4296162018A5054003874 @default.
• W4296162018 hasConcept C104317684 @default.
• W4296162018 hasConcept C159047783 @default.
• W4296162018 hasConcept C182615771 @default.
• W4296162018 hasConcept C2522874641 @default.
• W4296162018 hasConcept C2775832221 @default.
• W4296162018 hasConcept C2776315533 @default.
• W4296162018 hasConcept C2776441376 @default.
• W4296162018 hasConcept C2777637488 @default.
• W4296162018 hasConcept C2779256223 @default.
• W4296162018 hasConcept C2779489039 @default.
• W4296162018 hasConcept C2780923616 @default.
• W4296162018 hasConcept C501593827 @default.
• W4296162018 hasConcept C523546767 @default.
• W4296162018 hasConcept C54355233 @default.
• W4296162018 hasConcept C547475151 @default.
• W4296162018 hasConcept C55493867 @default.
• W4296162018 hasConcept C86803240 @default.
• W4296162018 hasConcept C89423630 @default.
• W4296162018 hasConceptScore W4296162018C104317684 @default.
• W4296162018 hasConceptScore W4296162018C159047783 @default.
• W4296162018 hasConceptScore W4296162018C182615771 @default.
• W4296162018 hasConceptScore W4296162018C2522874641 @default.
• W4296162018 hasConceptScore W4296162018C2775832221 @default.
• W4296162018 hasConceptScore W4296162018C2776315533 @default.
• W4296162018 hasConceptScore W4296162018C2776441376 @default.
• W4296162018 hasConceptScore W4296162018C2777637488 @default.
• W4296162018 hasConceptScore W4296162018C2779256223 @default.
• W4296162018 hasConceptScore W4296162018C2779489039 @default.
• W4296162018 hasConceptScore W4296162018C2780923616 @default.
• W4296162018 hasConceptScore W4296162018C501593827 @default.
• W4296162018 hasConceptScore W4296162018C523546767 @default.
• W4296162018 hasConceptScore W4296162018C54355233 @default.
• W4296162018 hasConceptScore W4296162018C547475151 @default.
• W4296162018 hasConceptScore W4296162018C55493867 @default.
• W4296162018 hasConceptScore W4296162018C86803240 @default.
• W4296162018 hasConceptScore W4296162018C89423630 @default.
• W4296162018 hasFunder F4320319095 @default.
• W4296162018 hasFunder F4320320769 @default.
• W4296162018 hasLocation W42961620181 @default.
• W4296162018 hasLocation W42961620182 @default.
• W4296162018 hasOpenAccess W4296162018 @default.
• W4296162018 hasPrimaryLocation W42961620181 @default.
• W4296162018 hasRelatedWork W2052389819 @default.
• W4296162018 hasRelatedWork W2094137434 @default.
• W4296162018 hasRelatedWork W2152655939 @default.
• W4296162018 hasRelatedWork W2329311130 @default.
• W4296162018 hasRelatedWork W2909648129 @default.
• W4296162018 hasRelatedWork W4281772394 @default.
• W4296162018 hasRelatedWork W4282981431 @default.
• W4296162018 hasRelatedWork W4283720103 @default.
• W4296162018 hasRelatedWork W4307243765 @default.

• next